Brookstone Capital Management purchased a new stake in shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) in the third quarter, according to the company in its most recent filing with the SEC. The firm purchased 375 shares of the company’s stock, valued at approximately $234,000.